Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120459508 | 12045950 | 8 | F | 20141205 | 20160913 | 20160208 | 20160919 | EXP | PHHY2014CA161850 | NOVARTIS | 73.61 | YR | F | Y | 0.00000 | 20160919 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120459508 | 12045950 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO (EVERY FOUR WEEKS) | 21008 | 20 | MG | /month | |||||||
| 120459508 | 12045950 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY FOUR WEEKS) | 21008 | 30 | MG | /month | |||||||
| 120459508 | 12045950 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, QMO (EVERY FOUR WEEKS) | 21008 | 40 | MG | /month | |||||||
| 120459508 | 12045950 | 4 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 50 MG, QMO (EVERY FOUR WEEKS) | 21008 | 50 | MG | /month | |||||||
| 120459508 | 12045950 | 5 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 60 MG, QMO (EVERY 28 DAYS) | 21008 | 60 | MG | /month | |||||||
| 120459508 | 12045950 | 6 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | 100 UG, TID | D | 0 | 100 | UG | TID | ||||||
| 120459508 | 12045950 | 7 | SS | FEMARA | LETROZOLE | 1 | Oral | 2.5 MG, QD (ONCE A DAY) | U | 0 | 2.5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120459508 | 12045950 | 1 | Metastatic carcinoid tumour |
| 120459508 | 12045950 | 6 | Metastatic carcinoid tumour |
| 120459508 | 12045950 | 7 | Metastatic carcinoid tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120459508 | 12045950 | OT |
| 120459508 | 12045950 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120459508 | 12045950 | Abdominal pain lower | |
| 120459508 | 12045950 | Alopecia | |
| 120459508 | 12045950 | Application site mass | |
| 120459508 | 12045950 | Arthralgia | |
| 120459508 | 12045950 | Back pain | |
| 120459508 | 12045950 | Blood pressure increased | |
| 120459508 | 12045950 | Body temperature decreased | |
| 120459508 | 12045950 | Breast cancer | |
| 120459508 | 12045950 | Diarrhoea | |
| 120459508 | 12045950 | Dizziness | |
| 120459508 | 12045950 | Eye inflammation | |
| 120459508 | 12045950 | Feeling abnormal | |
| 120459508 | 12045950 | Flushing | |
| 120459508 | 12045950 | Heart rate decreased | |
| 120459508 | 12045950 | Musculoskeletal pain | |
| 120459508 | 12045950 | Nasopharyngitis | |
| 120459508 | 12045950 | Pain in extremity | |
| 120459508 | 12045950 | Paraesthesia | |
| 120459508 | 12045950 | Second primary malignancy | |
| 120459508 | 12045950 | Stress | |
| 120459508 | 12045950 | Transient global amnesia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120459508 | 12045950 | 1 | 20141107 | 0 | ||
| 120459508 | 12045950 | 5 | 20160105 | 0 | ||
| 120459508 | 12045950 | 6 | 20141031 | 201411 | 0 |